BioCentury
ARTICLE | Company News

PTC sales and marketing update

October 26, 2015 7:00 AM UTC

The U.K.’s NICE has asked PTC to provide results of the ACT DMD confirmatory study and further evidence to support the cost of Translarna ataluren. The committee said the evidence submitted so far do...